Product name:Selumetinib
CAS: 606143-52-6
Molecular Formula: C17H15BrClFN4O3
Molecular Weight: 457.685
Product description:For the treatment of advanced non-small cell lung cancer (NSCLC). Company for beauty, mainly through regulating the Ras - Raf - key protein kinase MEK level in MEK - ERK pathway to curb including B - Raf - mutation of melanoma and K - Ras mutations in non-small cell lung cancer (NSCLC), many kinds of tumor growth. It is mainly used for the treatment of bile duct cancer, colorectal cancer, NSCLC, etc. At present, the department of the United States on behalf of, is in the treatment of non-small cell lung cancer Ⅲ phase of clinical trials. The us food and drug administration (FDA) approved the main targets more tyrosine kinase inhibitor (TKI) has more than ten kinds, including ash for ni, mo for hattush, sorafenib, etc.